[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-244848-105":53,"doc-detail-244848-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","request-for-proposal-clinical-trial-study-management-for-phase-ii-study-of-for-the-treatment-of-patients-with-severe-acute-pancreatitis","Request For Proposal - Clinical Trial Study Management for \"Phase II Study of for the Treatment of Patients with Severe Acute Pancreatitis\"","","This document is a Request for Proposal (RFP) from a biotechnology company seeking a full-service contract research organization (CRO) to manage a Phase II clinical study for the treatment of patients with severe acute pancreatitis. The study aims to evaluate the effects of a recombinant human pro-inflammatory phospholipid with diverse biologic effects. The selected CRO will be responsible for all aspects of the study, including proposal submission, study management, site coordination, site initiation, on-site monitoring, randomization, site contracting and payment management, biometrics, data management and reporting services, and management of central and core laboratory services. The RFP outlines the expected proposal submission schedule, including response due dates and award dates. It also details the required proposal components, such as project management approach, past performance, company information, statement of work, pricing, and contract terms. Interested parties are instructed to acknowledge receipt of the RFP and submit questions by a specified deadline.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":51,"@type":70,"position":76},"https://docshare.wps.com/template/general/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/request-for-proposal-clinical-trial-study-management-for-phase-ii-study-of-for-the-treatment-of-patients-with-severe-acute-pancreatitis/244848/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/request-for-proposal-clinical-trial-study-management-for-phase-ii-study-of-for-the-treatment-of-patients-with-severe-acute-pancreatitis/244848.png","ImageObject",442,249,{"name":88,"@type":89},"Gelato","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-09-23","2026-09-12",true,{"@type":98,"interactionType":99,"userInteractionCount":76},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the purpose of this RFP?","Question",{"text":108,"@type":109},"This RFP is to solicit proposals from eligible Contract Research Organizations (CROs) to manage a Phase II clinical study evaluating the effects of a recombinant human pro-inflammatory phospholipid in patients with severe acute pancreatitis.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What services is the company seeking from a CRO?",{"text":113,"@type":109},"The company is seeking full-service management, including proposal instructions, protocol synopsis, work breakdown, timeline, contractual terms, site coordination, monitoring, randomization, contracting, payment management, biometrics, data management, and core laboratory services.",{"name":115,"@type":106,"acceptedAnswer":116},"What are the key deadlines mentioned in the RFP?",{"text":117,"@type":109},"The RFP Response due date is June 3rd, the RFP Award date is June 19th, and the Finalized Contract and Statement of Work is July 31st.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},244848,1789222395,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":50,"category_name":51,"doc_title":59,"doc_description":61,"doc_content":60,"file_id":130,"file_url":131,"file_type":132,"file_size":133,"view_count":76,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":20,"language":134,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":135,"faqs":136,"seo_title":137,"seo_description":61,"update_tm":125,"read_time":47},19241457091524,"https://us-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","cbCaih4c4t0Rr4Ok","https://ap.wps.com/l/cbCaih4c4t0Rr4Ok","pdf",3218996,"English","# Request for Proposal (RFP)\n1. Project Management Approach\n2. Past Performance and Company Information\n3. Statement of Work\n4. Pricing\n5. Contracts","[{\"question\":\"What is the purpose of this RFP?\",\"answer\":\"This RFP is to solicit proposals from eligible Contract Research Organizations (CROs) to manage a Phase II clinical study evaluating the effects of a recombinant human pro-inflammatory phospholipid in patients with severe acute pancreatitis.\"},{\"question\":\"What services is the company seeking from a CRO?\",\"answer\":\"The company is seeking full-service management, including proposal instructions, protocol synopsis, work breakdown, timeline, contractual terms, site coordination, monitoring, randomization, contracting, payment management, biometrics, data management, and core laboratory services.\"},{\"question\":\"What are the key deadlines mentioned in the RFP?\",\"answer\":\"The RFP Response due date is June 3rd, the RFP Award date is June 19th, and the Finalized Contract and Statement of Work is July 31st.\"}]","Request For Proposal - Clinical Trial Study Management for \"Phase II Study of for the Treatment of Patients with Severe Acute Pancreatitis\" | PDF"]